Name
osaühing Medirad - R.
Registry code
10913902
Type
OÜ - Limited Liability Company
Status
Registered
Foundation date
27.02.2003 (21)
Financial year
01.01-31.12
Capital
2 556.00 €
Activity
86906 - Activities of diagnostic cabinets and centres, e.g. X-ray laboratories, magnetic resonance imaging and other similar cabinets
366 226 €
10 644 €
3%
1 375 €
(estimate is approximate)
237 883 €
6
Submitted
No tax arrears
4%
4%
| Owner | Representative | Beneficial owner | Roles | |
|---|---|---|---|---|
| Aktsiaselts Mammograaf 10233840 | 100% - 2 556.00 EUR | - | - | |
| SILVER RAUDSEPP 06.06.1987 (37) | - | Board member | Member of a higher management body, i.e. board member or supervisory board member | |
| OSAÜHING HANSA MEDICAL 10484631 | - | - | - | Founder |
| Vaksali Tervisekeskus OÜ 10608567 | - | - | - | Founder |
| 2019 31.10.2020 | 2020 30.06.2021 | 2021 08.09.2022 | 2022 20.07.2023 | 2023 30.06.2024 | |
|---|---|---|---|---|---|
| Total Revenue | 157 466 € | 196 911 € | 262 736 € | 297 592 € | 366 226 € |
| Net profit (loss) for the period | -8 521 € | -33 976 € | -11 214 € | 44 510 € | 10 644 € |
| Profit Margin | -5% | -17% | -4% | 15% | 3% |
| Current Assets | 64 507 € | 34 518 € | 23 757 € | 26 910 € | 60 900 € |
| Fixed Assets | 0 € | 0 € | 0 € | 219 042 € | 207 584 € |
| Total Assets | 64 507 € | 34 518 € | 23 757 € | 245 952 € | 268 484 € |
| Current Liabilities | 16 588 € | 20 575 € | 21 028 € | 18 713 € | 30 601 € |
| Non Current Liabilities | - | - | - | - | - |
| Total Liabilities | - | - | - | - | - |
| Share Capital | - | - | - | - | - |
| Equity | 47 919 € | 13 943 € | 2 729 € | 227 239 € | 237 883 € |
| Employees | 5 | 5 | 6 | 6 | 6 |
| Turnover | State taxes | Labor taxes and payments | Employees | |
|---|---|---|---|---|
| 2024 Q1 | - | 12 919.19 € | 13 614.15 € | 10 |
| 2023 Q4 | - | 12 135.64 € | 12 778.66 € | 10 |
| 2023 Q3 | - | 14 124.89 € | 14 972.41 € | 10 |
| 2023 Q2 | - | 15 141.36 € | 16 121.13 € | 11 |
| 2023 Q1 | - | 13 954.02 € | 14 865.76 € | 11 |
| 2022 Q4 | - | 13 416.27 € | 14 316.38 € | 11 |
| 2022 Q3 | - | 12 777.5 € | 13 642.65 € | 11 |
| 2022 Q2 | - | 10 103.31 € | 10 823.15 € | 10 |
| 2022 Q1 | - | 10 560.2 € | 11 315.37 € | 10 |
| 2021 Q4 | - | 10 680.71 € | 11 511.6 € | 9 |
| 2021 Q3 | - | 11 960.23 € | 12 896.79 € | 9 |
| 2021 Q2 | - | 11 522.97 € | 12 433.79 € | 8 |
| 2021 Q1 | - | 11 001.93 € | 11 869.9 € | 7 |
| 2020 Q4 | - | 14 769.22 € | 15 818.68 € | 7 |
| 2020 Q3 | - | 9 888.63 € | 10 691.23 € | 8 |
| 2020 Q2 | - | 7 652.53 € | 8 250.89 € | 8 |
| 2020 Q1 | - | 8 827.06 € | 9 494.66 € | 7 |
